Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Hims & Hers Health Inc before investing.
In this article, we go over a few key elements for understanding Hims & Hers Health Inc’s stock price such as:
- Hims & Hers Health Inc’s current stock price and volume
- Why Hims & Hers Health Inc’s stock price changed recently
- Upgrades and downgrades for HIMS from analysts
- HIMS’s stock price momentum as measured by its relative strength
About Hims & Hers Health Inc
(HIMS)
Before we jump into Hims & Hers Health Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
Want to learn more about Hims & Hers Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Hims & Hers Health Inc.
What Caused Hims & Hers Health Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 28, 2024, there were 0 analysts who downgraded Hims & Hers Health Inc’s stock and 2 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Hims & Hers Health Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Hims & Hers Health Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Hims & Hers Health Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Hims & Hers Health Inc
(HIMS) by visiting AAII Stock Evaluator.
Relative Price Strength of Hims & Hers Health Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of June 28, 2024, Hims & Hers Health Inc has a weighted four-quarter relative price strength of 20.95%, which translates to a Momentum Score of 95 and is considered to be Very Strong.
Want to learn more about how Hims & Hers Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Hims & Hers Health Inc Stock Price: Bottom Line
As of July 1, 2024, Hims & Hers Health Inc’s stock price is $21.42, which is up 6.09% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Hims & Hers Health Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.